Enzyme systems developer Dyadic settles dispute with SEC

In Florida, Dyadic announced a settlement with the SEC over charges of violations to the Securities and Exchange Act.

Under the terms of the settlement, Dyadic did not admit or deny the SEC findings, and agreed to a cease-and-desist order. The company said in a statement that it was glad to put the matter behind it and to renew its focus on “new products, improving and leveraging our technologies for use in such markets as cellulosic ethanol, industrial enzymes and pharmaceuticals and seeking mutually beneficial collaborations with leaders in such industries.”

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

Dyadic says it has received “generally recognized as safe” notice from FDA for enzyme platform

In Florida, Dyadic International said it had received a generally recognized as safe ("GRAS") , notice from the FDA for cellulase enzyme preparation derived from a genetically modified strain of the c...

Enzyme, gene expression leader Dyadic files suit against legal counsel

In Florida, upheaval continues at enzyme biotechnology company Dyadic. Founder and CEO Mark Emelfarb, who regained control of the company last summer after a proxy fight, has filed suit against Ern...

Dyadic receives last installment in $10 million payment from Codexis for enzyme production system

In Florida, Dyadic filed an SEC 8-K form confirming that the company has received the final installment in $10 million in upfront payments from Codexis for a license to utilize "the use of Dyadic's C1...

Biofuels enzyme developer Zymetis named to GoingGreen 50

In Maryland, enzyme developer Zymetis was named to the GoingGreen 50 as one of top companies in green technology based on market opportunity, innovation and customer growth. The company was formed ...

Codexis licenses biomanufacturing technology for $10 million, to improve enzyme production cycle time

In Florida, Dyadic International announced that it has licensed its biomanufacturing technology to Codexis for $10 million. Codexis said that it would use the technology in conjunction with its synthe...

Gushan to suspend biodiesel production at Fujian plant over tax dispute; attempting to transfer production to other plants

In China, Gushan Environmental Energy said that it will suspend biodisel production at its Fujian plant due to a dispute over consumption tax liabilities. The company said that it is attempting to arr...